---
category: news
title: "What We’re Reading: Common Asthma Inhaler Discontinued; AI in Health Care; FDA Approves Omalizumab for Food Allergies"
excerpt: "Discontinuation of asthma drug leaves patients in search of alternative; FDA’s approach to artificial intelligence (AI) raises opportunities and challenges; landmark FDA approval signals hope for millions with severe food allergies."
publishedDateTime: 2024-02-19T16:54:00Z
originalUrl: "https://www.ajmc.com/view/what-we-re-reading-common-asthma-inhaler-discontinued-ai-in-health-care-fda-approves-omalizumab-for-food-allergies"
webUrl: "https://www.ajmc.com/view/what-we-re-reading-common-asthma-inhaler-discontinued-ai-in-health-care-fda-approves-omalizumab-for-food-allergies"
type: article
quality: 16
heat: 16
published: false

provider:
  name: The American Journal of Managed Care
  domain: ajmc.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://cdn.sanity.io/images/0vv8moc6/ajmc/703de894e882d8a6da8c19964dc1ca71b969d30c-2000x1046.png?fit=crop&auto=format"
    width: 2000
    height: 1046
    isCached: true

secured: "eNQK57vuuB6hoNa7EHVOTX+I6lzjeHgXFwGqGiXwQ5MYDVjkHGk8CvVAtLklDBu9/TbK81i71l7guXfgZHcDDun46WDyvUA0FGcUFXbYGXVoxw+mioD+IcdimxBfNAYNumVKlafkjTi/5zTPNMcprubh/wPCyp5TZaKmSE4U2d1OhSn/s0IDhNUTr16Z/rccNO3Uqat6H26GeyiPfs+Ihy6ohi0Ot/g8+LcWBiQOGijk56XVa+j/XGyk8Y4h6v/yzzBfXki1tQKal0vKNdzSNUAvwmrXUhIkvK9lIKKTBL/pxAaZy7gv8HpmI9vv67sdOw727qLGA3mGYK4s7nttHtXaunNfkT8o9ECJ2kEbcpQ=;vgJiimPxuhLX64pdHPM7SA=="
---

